Gene Therapy Slows Huntington's 75%

ScienceAlert reported on September 25, 2025, that researchers in the United Kingdom have successfully trialed a gene therapy that slows the progression of Huntington's disease by 75%. Huntington's is a fatal neurodegenerative disorder that is typically inherited. The source material did not provide details on the specific research institutions involved, the number of trial participants, or the duration of the study. The mechanism of the gene therapy was also not detailed.

This development addresses a condition for which there is currently no cure. According to the researchers, the treatment could become the world's first approved gene therapy for Huntington's disease. The therapy is designed to target the genetic cause of the inherited disorder. Following the successful trial, the next procedural steps would involve seeking regulatory review for the treatment.